Sarepta Therapeutics exterior signage with logo on red brick wall

INSIGHTS

13 Apr 2026

RNA Medicine Finds Its Way Into Muscle

Sarepta's siRNA data confirm muscle-targeted RNA delivery is clinically viable for the first time, opening a new front in rare neuromuscul...

Scientist using pipette in vaccine research laboratory

RESEARCH

10 Apr 2026

Standard mRNA Had a Good Run. Then Came This.

Phase 3 data shows Arcturus' sa-mRNA vaccine produces more durable, functionally superior antibody responses than conventional mRNA

US Food and Drug Administration emblem close-up

REGULATORY

9 Apr 2026

RNA Medicine Reaches a Disease No Drug Has Ever Touched

Ionis wins Priority Review for zilganersen, targeting the first-ever treatment for a rare, fatal brain disease

University of Toronto campus sign representing AI mRNA research

INNOVATION

8 Apr 2026

A Self-Driving Lab Just Rewrote the Rules of mRNA Delivery

A self-driving AI platform has identified a novel lipid class that outperforms the delivery system at the core of Moderna's Covid-19 vacci...

Syringe with vaccine droplet in front of BioNTech logo backdrop

PARTNERSHIPS

7 Apr 2026

Sahin and Türeci Are Back at the Drawing Board

BioNTech co-founders will leave by year-end to launch a new next-gen mRNA company, with BioNTech taking a minority stake

Eli Lilly headquarters building with red Lilly logo

INVESTMENT

6 Apr 2026

RNA Gets a $2.4B Promotion at Eli Lilly

Eli Lilly acquires Orna Therapeutics for up to $2.4B, bringing circular RNA and in vivo CAR-T into its US pipeline

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.